期刊文献+

地塞米松改善脂多糖诱导的炎症反应及足细胞损伤 被引量:2

Dexamethasone Ameliorates Lipopolysaccharide-induced Inflammatory Reaction and Podocyte Injury
下载PDF
导出
摘要 目的 Nephrin在维持肾小球裂孔隔膜结构的完整性上起关键作用。本文观察地塞米松对脓毒症小鼠及体外培养足细胞nephrin磷酸化水平的影响,探讨其改善足细胞损伤的机制。方法脂多糖制备脓毒症小鼠模型,设正常对照组、脓毒症组、地塞米松治疗组。检测24 h尿蛋白和血清超敏C反应蛋白、白介素-6、降钙素原。RT-PCR、Western blot法检测nephrin mRNA的表达及磷酸化水平。体外培养小鼠永生化足细胞,分别给予脂多糖或地塞米松干预,TUNEL法检测足细胞凋亡,MTT法测定足细胞活力,并检测足细胞nephrin mRNA及磷酸化水平。结果在脓毒症小鼠实验中,脓毒症组24 h尿蛋白、血清超敏C反应蛋白、白介素-6、降钙素原水平升高,nephrin mRNA表达及磷酸化水平降低,地塞米松可改善脓毒症鼠尿蛋白及炎症指标,维持nephrin mRNA的表达及磷酸化水平。在体外培养的足细胞中,脂多糖诱导足细胞的凋亡,降低足细胞的活力,降低nephrin mRNA表达及磷酸化水平;而地塞米松明显减少足细胞的凋亡,刺激足细胞的活力,上调nephrin mRNA的表达及磷酸化水平。结论地塞米松拮抗脂多糖引起的炎症反应,改善nephrin的磷酸化水平,保护足细胞。 Objective Nephrin plays a key role in maintaining the structure of the slit diaphragm in the glo- merular filtration barrier. In this paper, we observed the effect of dexamethasone ( Dex ) on the level of nephrin phosphorylation in sepsis mice and euhured podocytes in vitro , and investigated the mechanism by which Dex amel- iorates podoeyte injury. Methods Mice were injected with lipopolysaecharide (LPS) to induce a sepsis model and randomly divided into three groups : control group ( n = 10 ), sepsis model group ( n = 10 ), sepsis + Dex treated group( n = 10). The levels of 24-hour urinary protein (24h UP), serum hypersensitive c-reactive protein (hs- CRP), interleukin-6 (IL-6) , and proealeitonin (PCT) were measured. The mRNA expression and phosphorylation of nephrin were detected by fluorescent quantitative reverse transeription-polymerase chain reaction (RT-PCR)and Western blotting respectively. Immortalized mouse podoeyte cells were cultured in vitro , intervened with LPS or Dex, while podoeyte apoptosis and viability were measured by TUNEL staining and MTT methods, respectively. Re- sults In sepsis mice, the levels of 24h UP, hs-CRP, IL-6, PCT were elevated while the mRNA expression and phosphorylation of nephrin were decreased. Dex significantly ameliorated proteinuria and inflammation indexes, but maintained the mRNA expression and phosphorylation level of nephrin. In cultured podocytes, LPS induced the ap- optosis of podoeytes, decreased the viability of podocytes, and down-regulated the mRNA expression and phosphoryl- ation of nephrin. However, Dex obviously inhibited podocyte apoptosis, stimulated podocyte viability, and up-regu- lated the mRNA expression and the phosphorylation of nephrin. Conclusion Dex can reverse LPS-indueed inflamma- tory reaction, improve nephrin phosphorylation, and protect podoeytes from injury.
出处 《解放军药学学报》 CAS 2014年第1期26-29,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
基金 湖北省自然科学基金资助项目 No.2011CDB020
关键词 地塞米松 脓毒症 NEPHRIN dexamethasone sepsis nephrin
  • 相关文献

参考文献13

  • 1邹敏书,余健,聂国明,何威逊,罗莉漫,徐洪涛.帕立骨化醇对糖尿病大鼠肾脏保护作用的机制探讨[J].解放军药学学报,2011,27(6):475-479. 被引量:6
  • 2任志龙,梁伟,丁国华,陈铖,周敏,徐婉,杨红霞.血管紧张素Ⅱ对足细胞nephrin磷酸化水平的影响[J].中华肾脏病杂志,2012,28(8):622-627. 被引量:6
  • 3Agrawal S,Guess AJ,Benndorf R, et al. Comparison of direct ac- tion of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects [ J ]. Mol Phannacol, 2011,80(3) :389 -399.
  • 4Kato T, Mizuno S, Kamimoto M. The decreases of nephrin and nu- clear WT1 in podocytes may cause albuminuria during the experi- mental sepsis in mice [ J ]. Biomed Res,2010,31 (6) : 363 - 369.
  • 5Wada T, Pippin JW, Marshall CB, et al. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins [ J ]. J Am Soc Nephrol, 2005,16(9) :2615 -2625.
  • 6Srivastava T,Sharma M ,Yew KH, et al. LPS and PAN-induced podo- cyte injury in an in vitro model of minimal change disease : changes in TLR profile[J]. J Cell Commun Signal,2013,7(1 ) :49 -60.
  • 7Deb DK,Wang Y,Zhang Z, et al. Molecular mechanism underly- ing 1,25-dihydroxyvitamin D regulation of nephrin gene expression [J].J Biol Chem,2011,286(37) :32011 -32017.
  • 8Guess A, Agrawal S, Wei CC, et al. Dose- and time-dependent glueocorticoid receptor signaling in podocytes [ J ]. Am J Physiol Renal Phvsio1.2010.299 (4): F845 - F853.
  • 9邹敏书,周建华,余健,何威逊,聂国明,罗莉漫,徐洪涛,丁冬胜,李琳.地塞米松对脓毒症新生大鼠nephrin的影响[J].临床儿科杂志,2012,30(4):367-371. 被引量:4
  • 10New LA, Keyvani Chahi A, Jones N. Direct regulation of nephrin tyrosine phosphorylation by Nck adaptor proteins [ J ]. J Biol Chem,2013,288 (3) : 1500 - 1510.

二级参考文献61

  • 1Turgut F, Bolton WK. Potential new therapeutic agents for diabet ic kidney disease[ J 1. Am J Kidney Dis ,2010,55 (5) :928-940.
  • 2de Zeeuw D, Agarwal R, Amdahl M, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes ( VITAL study) : a randomised con- trolled trial [J]. Lancet ,2010,376(9752) :1543-1551.
  • 3Eleftheriadis T, Antoniadi G, Liakopoulos V, et al. The effect of paricaleitol on osteoprotegerin production by human peripheral blood mononuclear cells[ J]. JRheumatol ,2009,36(4) :856-857.
  • 4Mizobuehi M, Morrissey J, Finch JL, et al. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats [ J ]. J Am Soc Nephrol ,2007,18 ( 6 ) : 1796-1806.
  • 5Mirkovi6K, van den Born J, Naris G, et al. Vitamin D in chronic kidney disease: new potential for intervention [ J ]. Curt Drug Targets, 2011,12( 1 ) :42-53.
  • 6Haller H,Ito S,Izzo JL Jr, et al. Olmesartan for the delay or pre- vention of microalbuminuria in type 2 diabetes [ J ]. N Engl J Med, 2011,364 (10) :907-917.
  • 7Li YC. Renoprotective effects of vitamin D analogs [ J ]. Kidney lnt, 2010,78(2) :134-139.
  • 8Zhang Y,Deb DK, Kong J, et al. Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist [ J ]. Am J Physiol Renal Physiol, 2009,297 ( 3 ) : F791 -F801.
  • 9Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans [ J ]. Hypertension, 2010,55 (5) : 1283-1288.
  • 10Fishbane S, Chittineni H, Packman M, et al. Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial[ J]. Am J Kidney Dis ,2009,54(4) :647-652.

共引文献12

同被引文献29

  • 1Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer[ J]. J Immunal,2009,182 ( 8 ) : 4499 - 4506.
  • 2Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock:2012[J]. Crit Care Med,2013,41 (2) : 580 - 637.
  • 3Kusmartsev S, Nefedova Y, Yoder D, et al. Antigen-specific inhibition of CD8 T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species [ J ]. J Immunol, 2014,172 (2) :989 - 999.
  • 4Van Rompaey N, Le Moine A. Myeloid-derived suppressor cells: characterization and expansion in models of endotoxemia and transplantation[J]. Methods Mol Biol,2011,677( 1 ) :169 - 180.
  • 5Tang BM, Craig JC, Eslick GD, et al. Use of corticostemids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis[ J]. Crit Care Med, 2009,37 (5) :1594 - 1603.
  • 6Moreno R, Sprung CL, Annane D, et al. Time course of organ failure in patients with septic shock treated with hydmcortisone: results of the Corticus study [ J ]. Intensive Care Med, 2011,37 ( 11 ) : 1765 - 1772.
  • 7Crossland H, Constantin-Teodosiu D, Greenhaff PL, et al. Low- dose dexamethasone prevents endotoxaemia-induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle J]. J Physio1,2010,588 ( 8 ) : 1333 - 1347.
  • 8Delano M J, Scumpia PO, Weinstein JS, et al. MyD88-dependent expansion of an immature GR-1 ( + ) CDllb ( + ) population induces T cell suppression and Th2 polarization in sepsis [ J ]. J Exp Med,2007,204(6) :1463 - 1474.
  • 9Vaknin I, Blinder L,Wang L, et al. A common pathway mediated through Toll-like receptors leads to T- and natural killer-cell immunosuppression [ J]. Blood ,2008,111 (3) :1437 - 1447.
  • 10Brudecki L, Ferguson DA, McCall CE, et al. Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response [ J ] .Infect Immun, 2012,80(6) :2026 -2034.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部